Literature DB >> 24168190

Regulation of mesenchymal phenotype by MicroRNAs in cancer.

Jinchun Yan, Kiranmai Gumireddy, Anping Li, Qihong Huang1.   

Abstract

Epithelial-mesenchymal transition (EMT) is a developmental process that converts epithelial cells into migratory and invasive cells. This process also plays an important role in cancer progression and metastasis by enabling tumor cells to leave primary sites. EMT is regulated by complex transcription networks and post-transcriptional modulators. MicroRNAs are single-stranded non-coding RNAs that represent a novel class of gene regulators. It has been shown that microRNAs are critical regulators of EMT process. The molecular mechanisms of EMT modulation by microRNAs include the suppression of transcription factors that directly regulate EMT and the down-regulation of cellular genes and pathways that are indirectly involved in EMT process. The expressions of microRNAs that control EMT process are dysregulated in cancer. In this review, we summarize the recent progress of microRNAs in EMT regulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24168190      PMCID: PMC4100067          DOI: 10.2174/15680096113136660098

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  74 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  The class I bHLH factors E2-2A and E2-2B regulate EMT.

Authors:  Verónica R Sobrado; Gema Moreno-Bueno; Eva Cubillo; Liam J Holt; M Angela Nieto; Francisco Portillo; Amparo Cano
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

4.  ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.

Authors:  Claude C Warzecha; Trey K Sato; Behnam Nabet; John B Hogenesch; Russ P Carstens
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

5.  MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA.

Authors:  William Kong; Hua Yang; Lili He; Jian-jun Zhao; Domenico Coppola; William S Dalton; Jin Q Cheng
Journal:  Mol Cell Biol       Date:  2008-09-15       Impact factor: 4.272

Review 6.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

7.  KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Kiranmai Gumireddy; Anping Li; Phyllis A Gimotty; Andres J Klein-Szanto; Louise C Showe; Dionyssios Katsaros; George Coukos; Lin Zhang; Qihong Huang
Journal:  Nat Cell Biol       Date:  2009-10-04       Impact factor: 28.824

8.  miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.

Authors:  Christoph A Gebeshuber; Kurt Zatloukal; Javier Martinez
Journal:  EMBO Rep       Date:  2009-02-27       Impact factor: 8.807

9.  Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition.

Authors:  Valentina Evdokimova; Cristina Tognon; Tony Ng; Peter Ruzanov; Natalya Melnyk; Dieter Fink; Alexey Sorokin; Lev P Ovchinnikov; Elai Davicioni; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Cell       Date:  2009-05-05       Impact factor: 31.743

10.  Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.

Authors:  Erica L McCoy; Ritsuko Iwanaga; Paul Jedlicka; Nee-Shamo Abbey; Lewis A Chodosh; Karen A Heichman; Alana L Welm; Heide L Ford
Journal:  J Clin Invest       Date:  2009-08-24       Impact factor: 14.808

View more
  16 in total

1.  Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis.

Authors:  Joseph U Igietseme; Yusuf Omosun; Tamas Nagy; Olga Stuchlik; Matthew S Reed; Qing He; James Partin; Kahaliah Joseph; Debra Ellerson; Zenas George; Jason Goldstein; Francis O Eko; Claudiu Bandea; Jan Pohl; Carolyn M Black
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 2.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

3.  Human aqueous humor exosomes.

Authors:  W Michael Dismuke; Pratap Challa; Iris Navarro; W Daniel Stamer; Yutao Liu
Journal:  Exp Eye Res       Date:  2015-01-22       Impact factor: 3.467

Review 4.  Fallopian tubal infertility: the result of Chlamydia trachomatis-induced fallopian tubal fibrosis.

Authors:  Hua Ling; Lipei Luo; Xingui Dai; Hongliang Chen
Journal:  Mol Cell Biochem       Date:  2021-10-15       Impact factor: 3.396

5.  MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor.

Authors:  Bo Sun; Xiaodong Gu; Zongyou Chen; Jianbin Xiang
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

6.  Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis.

Authors:  Joseph U Igietseme; Yusuf Omosun; Olga Stuchlik; Matthew S Reed; James Partin; Qing He; Kahaliah Joseph; Debra Ellerson; Brigid Bollweg; Zenas George; Francis O Eko; Claudiu Bandea; Hsi Liu; Genyan Yang; Wun-Ju Shieh; Jan Pohl; Kevin Karem; Carolyn M Black
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

7.  MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.

Authors:  Yosuke Konno; Peixin Dong; Ying Xiong; Fumihiko Suzuki; Jiabin Lu; Muyan Cai; Hidemichi Watari; Takashi Mitamura; Masayoshi Hosaka; Sharon J B Hanley; Masataka Kudo; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2014-08-15

8.  Gga-miR-101-3p Plays a Key Role in Mycoplasma gallisepticum (HS Strain) Infection of Chicken.

Authors:  Jiao Chen; Zaiwei Wang; Dingren Bi; Yue Hou; Yabo Zhao; Jianjun Sun; Xiuli Peng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

9.  High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.

Authors:  Priyank Shukla; Claus Vogl; Barbara Wallner; Doris Rigler; Mathias Müller; Sabine Macho-Maschler
Journal:  BMC Genomics       Date:  2015-11-16       Impact factor: 3.969

10.  Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.

Authors:  Peixin Dong; Kei Ihira; Ying Xiong; Hidemichi Watari; Sharon J B Hanley; Takahiro Yamada; Masayoshi Hosaka; Masataka Kudo; Junming Yue; Noriaki Sakuragi
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.